http://www.reportbuyer.com/rss.htmlDiscover insightful information you need to be fully informed on the Generic Drugs Market. Reports include data on the Threats and Opportunities of Generic Drugs in today’s market place. en-gbReportbuyerservice@reportbuyer.comenquiries@redwiredesign.comhttp://www.reportbuyer.com/pharma_healthcare/generic_drugs/generic_pharmaceuticals_industry_report_global.htmlThe Global Generic Pharmaceuticals Industry Report Do you know. . . . The top 7 best trading partners in the industry? Which company has the highest sales growth? Which companies have the highest levels of debt? This report is an in-depth financial evaluation of the Global Generic Pharmaceuticals Industry Report. 1ec1736b4b30ab5c7c6c52ab7629c8caWed, 11 Nov 2009 12:00:00 GBPharma & Healthcare/Generic Drugshttp://www.reportbuyer.com/pharma_healthcare/generic_drugs/partnering_global_generics_industry_2009.htmlPartnering is increasingly the choice for securing market share and business growth. . . Teva's recent acquisition of Barr Pharmaceuticals may be the latest headline grabbing deal, but industry and commerce alike must have a complete understanding of the medium-sized generic drug manufacturers. 64376a8cc5663acec1f07ac086b06546Sat, 10 Oct 2009 12:00:00 GBPharma & Healthcare/Generic Drugshttp://www.reportbuyer.com/pharma_healthcare/generic_drugs/generics_france.htmlDatamonitor's Generics in France industry profile is an essential resource for top-level data and analysis covering the generics industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information. Contains an executive summary and data on value, volume and/or segmentation Provides textual analysis of the industry's recent performance and future prospects Incorporates in-depth five forces competitive environment analysis and scorecards Includes a five-year forecast of the industry The leading companies are profiled with supporting key financial metrics Supported by the key macroeconomic and demographic data affecting the market Detailed information is included on market size, measured by value and/or volume Five forces scorecards provide an accessible yet in depth view of the market's competitive landscape Why you should buy this report Spot future trends and developments Inform your business decisions Add weight to presentations and marketing materials Save time carrying out entry-level research Market Definition The generics market consists of all sales of generic drugs for human use at ex-manufacturer prices. 5db2592b4db44a01560dbf9e350a31ffWed, 09 Sep 2009 12:00:00 GBPharma & Healthcare/Generic Drugshttp://www.reportbuyer.com/pharma_healthcare/generic_drugs/global_generics_1.htmlDatamonitor's Global Generics industry profile is an essential resource for top-level data and analysis covering the generics industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information. Contains an executive summary and data on value, volume and/or segmentation Provides textual analysis of the industry's recent performance and future prospects Incorporates in-depth five forces competitive environment analysis and scorecards Includes a five-year forecast of the industry The leading companies are profiled with supporting key financial metrics Supported by the key macroeconomic and demographic data affecting the market Detailed information is included on market size, measured by value and/or volume Five forces scorecards provide an accessible yet in depth view of the market's competitive landscape Why you should buy this report Spot future trends and developments Inform your business decisions Add weight to presentations and marketing materials Save time carrying out entry-level research Market Definition The generics market consists of all sales of generic drugs for human use at ex-manufacturer prices. 1f58d6b1ba6096baf834543a1636626fWed, 09 Sep 2009 12:00:00 GBPharma & Healthcare/Generic Drugshttp://www.reportbuyer.com/pharma_healthcare/generic_drugs/generics_germany.htmlDatamonitor's Generics in Germany industry profile is an essential resource for top-level data and analysis covering the generics industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information. Contains an executive summary and data on value, volume and/or segmentation Provides textual analysis of the industry's recent performance and future prospects Incorporates in-depth five forces competitive environment analysis and scorecards Includes a five-year forecast of the industry The leading companies are profiled with supporting key financial metrics Supported by the key macroeconomic and demographic data affecting the market Detailed information is included on market size, measured by value and/or volume Five forces scorecards provide an accessible yet in depth view of the market's competitive landscape Why you should buy this report Spot future trends and developments Inform your business decisions Add weight to presentations and marketing materials Save time carrying out entry-level research Market Definition The generics market consists of all sales of generic drugs for human use at ex-manufacturer prices. 8584e9617547b99d7b1ab27279d1f907Wed, 09 Sep 2009 12:00:00 GBPharma & Healthcare/Generic Drugshttp://www.reportbuyer.com/pharma_healthcare/generic_drugs/generics_asia_pacific.htmlDatamonitor's Generics in Asia-Pacific industry profile is an essential resource for top-level data and analysis covering the generics industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information. Contains an executive summary and data on value, volume and/or segmentation Provides textual analysis of the industry's recent performance and future prospects Incorporates in-depth five forces competitive environment analysis and scorecards Includes a five-year forecast of the industry The leading companies are profiled with supporting key financial metrics Supported by the key macroeconomic and demographic data affecting the market Detailed information is included on market size, measured by value and/or volume Five forces scorecards provide an accessible yet in depth view of the market's competitive landscape Why you should buy this report Spot future trends and developments Inform your business decisions Add weight to presentations and marketing materials Save time carrying out entry-level research Market Definition The generics market consists of all sales of generic drugs for human use at ex-manufacturer prices. 719e09bdfc72ac7a5ed304af1bd8d25eWed, 09 Sep 2009 12:00:00 GBPharma & Healthcare/Generic Drugshttp://www.reportbuyer.com/pharma_healthcare/generic_drugs/generics_europe.htmlDatamonitor's Generics in Europe industry profile is an essential resource for top-level data and analysis covering the generics industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information. Contains an executive summary and data on value, volume and/or segmentation Provides textual analysis of the industry's recent performance and future prospects Incorporates in-depth five forces competitive environment analysis and scorecards Includes a five-year forecast of the industry The leading companies are profiled with supporting key financial metrics Supported by the key macroeconomic and demographic data affecting the market Detailed information is included on market size, measured by value and/or volume Five forces scorecards provide an accessible yet in depth view of the market's competitive landscape Why you should buy this report Spot future trends and developments Inform your business decisions Add weight to presentations and marketing materials Save time carrying out entry-level research Market Definition The generics market consists of all sales of generic drugs for human use at ex-manufacturer prices. 8168c5e038148d39528539e9ec612affWed, 09 Sep 2009 12:00:00 GBPharma & Healthcare/Generic Drugshttp://www.reportbuyer.com/pharma_healthcare/generic_drugs/generics_netherlands.htmlDatamonitor's Generics in the Netherlands industry profile is an essential resource for top-level data and analysis covering the generics industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information. Contains an executive summary and data on value, volume and/or segmentation Provides textual analysis of the industry's recent performance and future prospects Incorporates in-depth five forces competitive environment analysis and scorecards Includes a five-year forecast of the industry The leading companies are profiled with supporting key financial metrics Supported by the key macroeconomic and demographic data affecting the market Detailed information is included on market size, measured by value and/or volume Five forces scorecards provide an accessible yet in depth view of the market's competitive landscape Why you should buy this report Spot future trends and developments Inform your business decisions Add weight to presentations and marketing materials Save time carrying out entry-level research Market Definition The generics market consists of all sales of generic drugs for human use at ex-manufacturer prices. ab5800f91d7d7959b231c13213f7091cWed, 09 Sep 2009 12:00:00 GBPharma & Healthcare/Generic Drugshttp://www.reportbuyer.com/pharma_healthcare/generic_drugs/generics_italy.htmlDatamonitor's Generics in Italy industry profile is an essential resource for top-level data and analysis covering the generics industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information. Contains an executive summary and data on value, volume and/or segmentation Provides textual analysis of the industry's recent performance and future prospects Incorporates in-depth five forces competitive environment analysis and scorecards Includes a five-year forecast of the industry The leading companies are profiled with supporting key financial metrics Supported by the key macroeconomic and demographic data affecting the market Detailed information is included on market size, measured by value and/or volume Five forces scorecards provide an accessible yet in depth view of the market's competitive landscape Why you should buy this report Spot future trends and developments Inform your business decisions Add weight to presentations and marketing materials Save time carrying out entry-level research Market Definition The generics market consists of all sales of generic drugs for human use at ex-manufacturer prices. eb74f879eff021b06f9982f8a7c67169Wed, 09 Sep 2009 12:00:00 GBPharma & Healthcare/Generic Drugshttp://www.reportbuyer.com/pharma_healthcare/generic_drugs/generics_canada.htmlDatamonitor's Generics in Canada industry profile is an essential resource for top-level data and analysis covering the generics industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information. Contains an executive summary and data on value, volume and/or segmentation Provides textual analysis of the industry's recent performance and future prospects Incorporates in-depth five forces competitive environment analysis and scorecards Includes a five-year forecast of the industry The leading companies are profiled with supporting key financial metrics Supported by the key macroeconomic and demographic data affecting the market Detailed information is included on market size, measured by value and/or volume Five forces scorecards provide an accessible yet in depth view of the market's competitive landscape Why you should buy this report Spot future trends and developments Inform your business decisions Add weight to presentations and marketing materials Save time carrying out entry-level research Market Definition The generics market consists of all sales of generic drugs for human use at ex-manufacturer prices. 5c2c0ca12330956786bc5beb476c7ac3Wed, 09 Sep 2009 12:00:00 GBPharma & Healthcare/Generic Drugshttp://www.reportbuyer.com/pharma_healthcare/generic_drugs/generics_japan.htmlDatamonitor's Generics in Japan industry profile is an essential resource for top-level data and analysis covering the generics industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information. Contains an executive summary and data on value, volume and/or segmentation Provides textual analysis of the industry's recent performance and future prospects Incorporates in-depth five forces competitive environment analysis and scorecards Includes a five-year forecast of the industry The leading companies are profiled with supporting key financial metrics Supported by the key macroeconomic and demographic data affecting the market Detailed information is included on market size, measured by value and/or volume Five forces scorecards provide an accessible yet in depth view of the market's competitive landscape Why you should buy this report Spot future trends and developments Inform your business decisions Add weight to presentations and marketing materials Save time carrying out entry-level research Market Definition The generics market consists of all sales of generic drugs for human use at ex-manufacturer prices. 9f888131809d9bea37d374519e48d2fbWed, 09 Sep 2009 12:00:00 GBPharma & Healthcare/Generic Drugshttp://www.reportbuyer.com/pharma_healthcare/generic_drugs/generics_belgium.htmlDatamonitor's Generics in Belgium industry profile is an essential resource for top-level data and analysis covering the generics industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information. Contains an executive summary and data on value, volume and/or segmentation Provides textual analysis of the industry's recent performance and future prospects Incorporates in-depth five forces competitive environment analysis and scorecards Includes a five-year forecast of the industry The leading companies are profiled with supporting key financial metrics Supported by the key macroeconomic and demographic data affecting the market Detailed information is included on market size, measured by value and/or volume Five forces scorecards provide an accessible yet in depth view of the market's competitive landscape Why you should buy this report Spot future trends and developments Inform your business decisions Add weight to presentations and marketing materials Save time carrying out entry-level research Market Definition The generics market consists of all sales of generic drugs for human use at ex-manufacturer prices. bb4451e824fe24da81862d36e9eec2a9Wed, 09 Sep 2009 12:00:00 GBPharma & Healthcare/Generic Drugshttp://www.reportbuyer.com/pharma_healthcare/generic_drugs/generics_spain.htmlDatamonitor's Generics in Spain industry profile is an essential resource for top-level data and analysis covering the generics industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information. Contains an executive summary and data on value, volume and/or segmentation Provides textual analysis of the industry's recent performance and future prospects Incorporates in-depth five forces competitive environment analysis and scorecards Includes a five-year forecast of the industry The leading companies are profiled with supporting key financial metrics Supported by the key macroeconomic and demographic data affecting the market Detailed information is included on market size, measured by value and/or volume Five forces scorecards provide an accessible yet in depth view of the market's competitive landscape Why you should buy this report Spot future trends and developments Inform your business decisions Add weight to presentations and marketing materials Save time carrying out entry-level research Market Definition The generics market consists of all sales of generic drugs for human use at ex-manufacturer prices. 6956b136bbc18232fe27279d3cfe0137Wed, 09 Sep 2009 12:00:00 GBPharma & Healthcare/Generic Drugshttp://www.reportbuyer.com/pharma_healthcare/generic_drugs/generics_united_kingdom.htmlDatamonitor's Generics in the United Kingdom industry profile is an essential resource for top-level data and analysis covering the generics industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information. Contains an executive summary and data on value, volume and/or segmentation Provides textual analysis of the industry's recent performance and future prospects Incorporates in-depth five forces competitive environment analysis and scorecards Includes a five-year forecast of the industry The leading companies are profiled with supporting key financial metrics Supported by the key macroeconomic and demographic data affecting the market Detailed information is included on market size, measured by value and/or volume Five forces scorecards provide an accessible yet in depth view of the market's competitive landscape Why you should buy this report Spot future trends and developments Inform your business decisions Add weight to presentations and marketing materials Save time carrying out entry-level research Market Definition The generics market consists of all sales of generic drugs for human use at ex-manufacturer prices. 1a8f6315b47cf9f4221ccb912b0e1eadWed, 09 Sep 2009 12:00:00 GBPharma & Healthcare/Generic Drugshttp://www.reportbuyer.com/pharma_healthcare/generic_drugs/generics_united_states.htmlDatamonitor's Generics in the United States industry profile is an essential resource for top-level data and analysis covering the generics industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information. Contains an executive summary and data on value, volume and/or segmentation Provides textual analysis of the industry's recent performance and future prospects Incorporates in-depth five forces competitive environment analysis and scorecards Includes a five-year forecast of the industry The leading companies are profiled with supporting key financial metrics Supported by the key macroeconomic and demographic data affecting the market Detailed information is included on market size, measured by value and/or volume Five forces scorecards provide an accessible yet in depth view of the market's competitive landscape Why you should buy this report Spot future trends and developments Inform your business decisions Add weight to presentations and marketing materials Save time carrying out entry-level research Market Definition The generics market consists of all sales of generic drugs for human use at ex-manufacturer prices. 7fba18717a7667159dce3cadeaedd4f6Wed, 09 Sep 2009 12:00:00 GBPharma & Healthcare/Generic Drugshttp://www.reportbuyer.com/pharma_healthcare/generic_drugs/generics_china.htmlDatamonitor's Generics in China industry profile is an essential resource for top-level data and analysis covering the generics industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information. Contains an executive summary and data on value, volume and/or segmentation Provides textual analysis of the industry's recent performance and future prospects Incorporates in-depth five forces competitive environment analysis and scorecards Includes a five-year forecast of the industry The leading companies are profiled with supporting key financial metrics Supported by the key macroeconomic and demographic data affecting the market Detailed information is included on market size, measured by value and/or volume Five forces scorecards provide an accessible yet in depth view of the market's competitive landscape Why you should buy this report Spot future trends and developments Inform your business decisions Add weight to presentations and marketing materials Save time carrying out entry-level research Market Definition The generics market consists of all sales of generic drugs for human use at ex-manufacturer prices. b3d5b94c47a592926f4210396fc88a23Wed, 09 Sep 2009 12:00:00 GBPharma & Healthcare/Generic Drugshttp://www.reportbuyer.com/pharma_healthcare/generic_drugs/world_generics_market.htmlImpending patent expiries, increasing competition and changes in legislation: where will generics go from 2009 onwards? Our new report - World Generics Market 2009-2024 - explains the opportunities and challenges thereThe generic pharmaceuticals sector has been expanding strongly in recent years as the need for cheaper medicines worldwide has increased. The next five years from 2009 will see more leading drugs going off patent, thus increasing opportunities for generics producers. Regulations favouring generic products give cause for optimism in the generics sector, while still leaving scope for novel branded drugs. 5c1fe43e0d2511faabaef3b992748317Wed, 26 Aug 2009 12:00:00 GBPharma & Healthcare/Generic Drugshttp://www.reportbuyer.com/pharma_healthcare/generic_drugs/generic_strategies_emerging_markets.html The emerging markets are luring a growing number of pharma companies looking to compensate for the diminishing revenues in developed markets. Latin America and Central and Eastern Europe (CEE) are showing strong growth rates, proving to be lucrative targets for firms aiming to expand their foothold, initially as a generics player, but also providing a foundation for subsequent brand penetration. Provides an overview of recent events affecting the generics market in the CEE and Latin America Identifies the different barriers and opportunities for growth in the CEE and Latin America Provides insight into the growth drivers of multinational and domestic generic players operating in these regions Identifies key strategies for entrance and expansion in these markets Sales growth in the CEE generics market is slowing due to increasing competition among generics players, while the Latin American market continues to grow, with significant room for further expansion. 962b6cb4b14ec3002ef200c3bde4c22cSat, 08 Aug 2009 12:00:00 GBPharma & Healthcare/Generic Drugshttp://www.reportbuyer.com/pharma_healthcare/generic_drugs/emerging_opportunities_controlled_release_generic_drugs.htmlThis new report identifies 30 controlled-release drugs valued at US$15 billion, many of which will be losing patent protection in the medium term. From emerging specialist companies to established generic producers, alternative drug delivery technologies are increasingly being seen as a route to a competitive edge in the generics industry. While controlled-release products have traditionally been developed towards the patent-expiry, companies are now beginning to look at controlled-release delivery earlier in the product life-cycle and, in some cases, are launching immediate- and controlled-release versions of new drugs to address the differing needs of patients. fb76fc959b4853a0bfa44342f691f882Sat, 08 Aug 2009 12:00:00 GBPharma & Healthcare/Generic Drugshttp://www.reportbuyer.com/pharma_healthcare/generic_drugs/generic_drug_market_canada.htmlCanada represents one of the largest markets for pharmaceuticals in the world, with a huge potential for generics. In 2008, generics accounted for more than 51% prescriptions and around 23% sales of the total pharmaceutical market. The Canadian generics market is benefitting from several factors such as patent expiry of several blockbuster drugs, lower costs, cost containment measures by the government and rapidly ageing population, according to Generic Drug Market in Canada, a comprehensive market research report by RNCOS. 8280510e84a06236ede52c40bd7d33b3Sat, 08 Aug 2009 12:00:00 GBPharma & Healthcare/Generic Drugs